Eur Rev Med Pharmacol Sci 2020; 24 (7): 3434-3436
DOI: 10.26355/eurrev_202004_20794

In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention?

M.G. Carta, G. Orrù, A. Scano, F. Coghe, G. Nunnari, G. Facchini, F.G. Numis, M. Berretta

Department of Medical Sciences and Public Health, University of Cagliari, Italy. orru@unica.it

Free PDF Download

To cite this article

M.G. Carta, G. Orrù, A. Scano, F. Coghe, G. Nunnari, G. Facchini, F.G. Numis, M. Berretta
In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 7
Pages: 3434-3436
DOI: 10.26355/eurrev_202004_20794

Keywords Related articles:

  1. Faced with 2019-nCoV outbreak, we have learned our lessons from SARS of 2003
  2. From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality
  3. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2
  4. Editorial – Coronavirus disease 2019 and people living with HIV: clinical considerations
  5. Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak